The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway
Open accessAbstract
// Shi-Peng Li 1, * , Hai-Xu Xu 3, * , Yao Yu 1, * , Jin-Dan He 1, * , Zhen Wang 1 , Yan-Jie Xu 1 , Chang-Ying Wang 3 , Hai-Ming Zhang 1, 2 , Rong-Xin Zhang 4 , Jian-Jun Zhang 1, 2 , Zhi Yao 3 , Zhong-Yang Shen 1, 2 1 First Central Clinical College, Tianjin Medical University, Tianjin, P.R. China 2 Oriental Organ Transplant Center of Tianjin First Central Hospital, Key Laboratory of Organ Transplantation of Tianjin, Tianjin, P.R.China 3 Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Immuno Microenvironment and Disease of the Educational Ministry, Tianjin Medical University, Tianjin, P.R.China 4 Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Basic Medical College, Tianjin Medical University, Tianjin, P.R.China * These authors have contributed equally to this work Correspondence to: Jian-Jun Zhang, email: zhangjianjun9999@yeah.net Zhong-Yang Shen, email: zhongyangshen@vip.sina.com Rong-Xin Zhang, email: rongxinz@yahoo.com Zhi Yao, email: yaozhi@tijmu.edu.cn Keywords: hepatocellular carcinoma, lncRNA HULC, epithelial-mesenchymal transition, miR-200a-3p, ZEB1 Received: November 29, 2015 Accepted: May 14, 2016 Published: June 7, 2016 ABSTRACT Highly upregulated in liver cancer (HULC), a lncRNA that is considered a key molecule in human liver cancer, has recently been revealed to be involved in hepatocellular carcinoma (HCC) development and progression [1, 2]. It has been reported that HULC can promote tumor invasion and metastasis of HCC, but its function and mechanism of action in HCC have not been elucidated. In this study, we found that HULC was aberrantly up-regulated in HCC tissues and associated with TNM stage, intrahepatic metastases, HCC recurrence, and postoperative survival. HULC depletion inhibited the growth and metastasis of HCC cell lines in vitro and in vivo . Moreover, HULC contributes to ZEB1-induced epithelial-mesenchymal transition (EMT), a requirement for tumor invasion and metastasis that plays a key role in cancer progression. This effect of ZEB1 was inhibited by HULC siRNA. We conclude that the HULC functioned as a competing endogenous RNA (ceRNA) to mediate EMT via up-regulating ZEB1. In this way, it sequesters the miR-200a-3p signaling pathway to facilitate HCC metastasis. HULC comes into play as an oncogene in HCC, acting mechanistically by inducing HCC cells to activate EMT. Such an effect promotes tumor progression and metastasis through the miR-200a-3p/ZEB1 signaling pathway. The identification of this novel pathway that links high expression levels of HULC with EMT in HCC cells may serve as the foundation for the development of novel anti-tumor therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
CONG, N., DU, P., ZHANG, A., SHEN, F., SU, J., PU, P., WANG, T., ZJANG, J., KANG, C., & ZHANG, Q. (2013) · Oncology Reports · doi:10.3892/or.2013.2267 · Cited by 160
RetractedPeng, W., Gao, W., & Feng, J. (2014) · Medical Oncology · doi:10.1007/s12032-014-0346-4 · Cited by 144
RetractedLv, X., Li, L., Lv, L., Qu, X., Jin, S., Li, K., Deng, X., Cheng, L., He, H., & Dong, L. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0245-3 · Cited by 91
RetractedMiR-200 suppresses metastases of colorectal cancer through ZEB1
Sun, J., Ding, W., Zhi, J., & Chen, W. (2015) · Tumor Biology · doi:10.1007/s13277-015-3822-3 · Cited by 23
RetractedA ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654
Zheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
Cited by
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Wong, C.-M., Tsang, F. H.-C., & Ng, I. O.-L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.169 · Cited by 424
Xiong, H., Ni, Z., He, J., Jiang, S., Li, X., He, J., Gong, W., Zheng, L., Chen, S., Li, B., et al. (2017) · Oncogene · doi:10.1038/onc.2016.521 · Cited by 362
Self-citationNon-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Klingenberg, M., Matsuda, A., Diederichs, S., & Patel, T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.009 · Cited by 354
The multiverse nature of epithelial to mesenchymal transition
Simeone, P., Trerotola, M., Franck, J., Cardon, T., Marchisio, M., Fournier, I., Salzet, M., Maffia, M., & Vergara, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.004 · Cited by 98
Rusu, I., Pirlog, R., Chiroi, P., Nutu, A., Puia, V. R., Fetti, A. C., Rusu, D. R., Berindan-Neagoe, I., & Al Hajjar, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012370 · Cited by 27
Metadata
- Authors
- Li, S.-P., Xu, H.-X., Yu, Y., He, J.-D., Wang, Z., Xu, Y.-J., Wang, C.-Y., Zhang, H.-M., Zhang, R.-X., Zhang, J.-J., Yao, Z., & Shen, Z.-Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-06-07
- Volume
- 7
- Issue
- 27
- Pages
- 42431-42446
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2417073627
- Cited by
- 268
- References
- 45
- FWCI
- 17.59
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. https://app.cochat.ai/papers/10.18632/oncotarget.9883
- The paper
- Li, S.-P., Xu, H.-X., Yu, Y., He, J.-D., Wang, Z., Xu, Y.-J., Wang, C.-Y., Zhang, H.-M., Zhang, R.-X., Zhang, J.-J., Yao, Z., & Shen, Z.-Y. (2106). LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. https://doi.org/10.18632/oncotarget.9883
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.